PST-611 is a first-in-class non-viral vectorized therapy for the treatment of dry AMD/GA ... safety and durability of effect in a robust preclinical plan. This program is the first milestone in the ...
During the hearing, MCG’s Joint Commissioner confirmed that the land designated for the project remains “clean,” and any future plans would strictly comply with the Solid Waste Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback